Results 151 to 160 of about 2,755,321 (217)

Isoniazid preventive therapy in child household contacts of adults with active TB in Bamako, Mali. [PDF]

Public Health Action, 2021
Tolofoudie M, Somboro A, Diarra B, Sarro YS, Drame HB, Togo ACG, Sanogo M, Dembele A, Togun T, Nkereuwem E, Baya B, Konate B, Egere U, Traore M, Maiga M, Saliba-Shaw K, Kampmann B, Diallo S, Doumbia S, Sylla M.   +19 more
europepmc   +1 more source

Adverse Drug Reactions Related to Isoniazid Preventive Therapy Among Persons Living With HIV on Dolutegravir-Based Regimens in Uganda Between July 2019 and March 2020. [PDF]

J Acquir Immune Defic Syndr
Nalugga EA, Musaazi J, Manabe YC, Kalema N, Castelnuovo B, Odongpiny EAL, Nabukenya-Mudiope MG, Kavuma P, Kigozi J, Muganzi A, Alamo S, Namayanja G, Lukoye D, Ssempiira J, Zawedde-Muyanja S.   +14 more
europepmc   +1 more source

Perspectives of Healthcare Professionals on Factors Limiting Implementation of Isoniazid Preventive Therapy in People Living with HIV in Eritrea: A Qualitative Study. [PDF]

Risk Manag Healthc Policy, 2022
Russom M, Jeannetot DYB, Tesfamariam S, Stricker BH, Verhamme K.   +4 more
europepmc   +1 more source

Assessment of contextual factors shaping delivery and uptake of isoniazid preventive therapy among people living with HIV in Dar es salaam, Tanzania. [PDF]

BMC Infect Dis, 2022
Nyarubamba RF, Silumbwe A, Jacobs C, Maritim P, Mdoe P, Zulu JM.   +5 more
europepmc   +1 more source

Lower Tuberculosis Incidence Among People With HIV Who Completed Isoniazid Preventive Therapy in Ukraine, a High-Burden Multidrug-Resistant Tuberculosis Setting: A Retrospective Cohort Study. [PDF]

Clin Infect Dis
Sodeke O, Shah NS, Pals S, Riabokon S, Samsonova O, Mishara F, Doan I, Hetman L, Barzilay E, Podolchak N, Da Silva J.   +10 more
europepmc   +1 more source

Isoniazid preventive therapy modulates Mycobacterium tuberculosis-specific T-cell responses in individuals with latent tuberculosis and type 2 diabetes. [PDF]

Sci Rep
Ssekamatte P, Sitenda D, Nabatanzi R, Nakibuule M, Kibirige D, Kyazze AP, Kateete DP, Bagaya BS, Sande OJ, van Crevel R, Cose S, Biraro IA.   +11 more
europepmc   +1 more source

Childhood Tuberculosis and Isoniazid Preventive Therapy Among Household Contacts of Sputum Positive Pulmonary Tuberculosis Patients: A Descriptive Observational Study. [PDF]

Cureus, 2022
Shanbag N, Haseeb M, Engade M, Siddiqui MS, Badaam KM, Nelanuthala M.   +5 more
europepmc   +1 more source

Diminished <i>Mycobacterium tuberculosis</i>-specific T-cell Responses During Pregnancy in Women With HIV and Receiving Isoniazid Preventive Therapy. [PDF]

Open Forum Infect Dis
Saha A, Escudero JN, Layouni T, Mecha J, Maleche-Obimbo E, Matemo D, Kinuthia J, John-Stewart G, Richardson BA, LaCourse SM, Shah JA.   +10 more
europepmc   +1 more source

Isoniazid preventive therapy use among adult people living with HIV in Zimbabwe. [PDF]

Int J STD AIDS, 2021
Takamiya M, Takarinda K, Balachandra S, Godfrey M, Radin E, Hakim A, Pearson ML, Choto R, Sandy C, Maphosa T, Rogers JH.   +10 more
europepmc   +1 more source

The effect of an intervention to promote isoniazid preventive therapy on leadership and management abilities. [PDF]

Public Health Action
Christian C, Kakande E, Nahurira V, Balzer LB, Owaraganise A, Nugent JR, DiIeso W, Rast D, Kabami J, Peretz JJ, Camlin CS, Shade SB, Kamya MR, Havlir DV, Chamie G.   +14 more
europepmc   +1 more source